BohnBCHadguRMPopeHEShusterJE.Oral metolazone versus intravenous chlorothiazide as an adjunct to loop diuretics for diuresis in acute decompensated heart failure with reduced ejection fraction. Hosp Pharm. 2019;54(6):351-357. doi:10.1177/0018578718795855
2.
CisowskaTPanIZBiskupiakJShahKSFangJCJacobsJA.Metolazone versus intravenous chlorothiazide for decompensated heart failure sequential nephron blockade: a retrospective cohort study. J Card Fail. 2022;28(8):1367-1371. doi:10.1016/j.cardfail.2022.05.011
3.
MoranvilleMPChoiSHoggJAndersonASRichJD.Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance. Cardiovasc Ther. 2015;33(2):42-49. doi:10.1111/1755-5922.12109
4.
ShulenbergerCEJiangADevabhakthuniSIvaturiVLiuTReedBN.Efficacy and safety of intravenous chlorothiazide versus oral metolazone in patients with acute decompensated heart failure and loop diuretic resistance. Pharmacotherapy. 2016;36(8):852-860. doi:10.1002/phar.1798
5.
GibsonCMBeardMMEscanoAK, et alMetolazone versus chlorothiazide in acute heart failure patients with diuretic resistance and renal dysfunction: a retrospective cohort study. J Cardiovasc Pharmacol. 2024;84:451-456. doi:10.1097/FJC.0000000000001623
6.
CoxZLHungRLenihanDJTestaniJM.Diuretic strategies for loop diuretic resistance in acute heart failure: the 3T trial. JACC Heart Fail. 2020;8(3):157-168. doi:10.1016/j.jchf.2019.09.012
7.
SteuberTDJanzenKMHowardML.A systematic review and meta-analysis of metolazone compared to chlorothiazide for treatment of acute decompensated heart failure. Pharmacotherapy. 2020;40(9):924-935. doi:10.1002/phar.2440
